Kai Pharmaceuticals

Drug discovery and development for treating secondary hyperparathyroidism

placeSan Francisco, California, United States calendar_todayFounded 2002 language kaipharmaceuticals.com

Registered entities

Investor mix

10 investors on record; lead investors include Skyline Ventures, Aberdare Ventures, Investor Growth Capital; 1 has since exited.

Investor typeCountShare
Venture capital880%
Private equity110%
Other / undisclosed110%
Coming soon